#dna methylation validation

Discover 2 curated intelligence briefings related to this specific topic.

Genetic Promises Die in the Billing Department
Health & Medicine

Genetic Promises Die in the Billing Department

While clinical trials show 90% immune response rates for pancreatic cancer vaccines, the actual deployment of genomic medicine is being throttled not by science, but by the inability of health plans to accurately price and pay for individualized care.

Read Analysis
Genomic Datasets and NAMs Obviate Traditional Lab Validation
Health & Medicine

Genomic Datasets and NAMs Obviate Traditional Lab Validation

Traditional private lab validation for DNA methylation is slow and expensive. The emergence of New Approach Methodologies (NAMs) and expansive datasets like GeneDx Infinity provides a high-fidelity alternative for biomarker verification.

Read Analysis